NDC11 46708066105
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 46708-0661-05 | 46708-0661 |
| 46708-0661-5 | 46708-0661 |
| 46708-661-05 | 46708-661 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Brimonidine Tartrate ophthalmic solution, 0.15% | BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% | Alembic Pharmaceuticals Limited | e1ea003e-3dd9-41c7-9119-d1f209b9820b | 2023-07-06 | Warnings, Adverse reactions | 46708-661-05 46708-661 46708066105 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.